BioXcel Therapeutics Ownership | Who Owns BioXcel Therapeutics?
BioXcel Therapeutics Ownership Summary
BioXcel Therapeutics is owned by 44.57% institutional investors, 3.97% insiders, and 51.46% retail investors. Millennium management is the largest institutional shareholder, holding 15.86% of BTAI shares. BSO Bio Santé C is the top mutual fund, with 2.26% of its assets in BioXcel Therapeutics shares.
BTAI Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | BioXcel Therapeutics | 44.57% | 3.97% | 51.46% |
| Sector | Healthcare Stocks | 35.58% | 11.87% | 52.55% |
| Industry | Biotech Stocks | 35.75% | 11.83% | 52.41% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Millennium management | 1.94M | 15.86% | $2.60M |
| Armistice capital | 1.91M | 15.65% | $2.56M |
| Vanguard group | 292.75K | 2.06% | $468.40K |
| Oaktree capital management lp | 241.19K | 1.98% | $323.19K |
| Geode capital management | 230.17K | 1.89% | $308.73K |
| Xtx topco | 113.36K | 1.45% | $290.21K |
| Blackrock | 440.69K | 1.43% | $564.08K |
| Jones financial companies lllp | 131.79K | 1.08% | $166.05K |
| Man group | 96.47K | 0.79% | $129.27K |
| State street | 92.12K | 0.75% | $123.44K |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Oaktree fund advisors | 42.91K | 0.10% | $57.50K |
| Armistice capital | 1.91M | 0.05% | $2.56M |
| Xtx topco | 113.36K | 0.02% | $290.21K |
| Oaktree capital management lp | 241.19K | 0.01% | $323.19K |
| Eversource wealth advisors | 1.77K | 0.00% | $73.86K |
| Portfolio strategies | 12.18K | 0.00% | $16.32K |
| Millennium management | 1.94M | 0.00% | $2.60M |
| Wiley bros.-aintree capital | 80.86K | 0.00% | $108.36K |
| Diversify wealth management | 15.00K | 0.00% | $15.60K |
| Man group | 96.47K | 0.00% | $129.27K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Armistice capital | 1.91M | 0.05% | 1.91M |
| Millennium management | 1.94M | 0.00% | 101.57K |
| Vanguard group | 292.75K | - | 100.63K |
| Xtx topco | 113.36K | 0.02% | 89.94K |
| Vanguard fiduciary trust | 84.92K | - | 84.92K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 440.69K | - | -887.38K |
| Ameriprise financial | - | - | -579.16K |
| Jane street group | - | - | -127.50K |
| Bank of new york mellon | - | - | -123.08K |
| Gsa capital partners llp | - | - | -120.10K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Armistice capital | 1.91M | 0.05% | 1.91M | $2.56M |
| Vanguard fiduciary trust | 84.92K | - | 84.92K | $113.79K |
| Wiley bros.-aintree capital | 80.86K | 0.00% | 80.86K | $108.36K |
| Beacon pointe advisors | 18.88K | 0.00% | 18.88K | $25.30K |
| Aqr capital management | 14.36K | - | 14.36K | $18.38K |
Sold Out
| Holder | Change |
|---|---|
| Mount yale investment advisors | -1.00 |
| Federation des caisses desjardins du quebec | -1.00 |
| Nelson, van denburg & campbell wealth management group | -4.00 |
| National bank of canada /fi/ | -6.00 |
| Point72 (difc) | -35.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 39 | -4.88% | 5,441,395 | 53.85% | 44 | 7.18% | 18 | -14.29% | 7 | - |
| Dec 31, 2025 | 20 | -44.44% | 818,099 | -65.30% | 5 | 0.64% | 9 | -60.87% | 3 | - |
| Sep 30, 2025 | 16 | -51.52% | 549,847 | -11.04% | 7 | 11.29% | 10 | -33.33% | 1 | -85.71% |
| Jun 30, 2025 | 32 | 3.23% | 613,025 | 61.47% | 7 | 797.16% | 14 | 100.00% | 7 | -70.83% |
| Mar 31, 2025 | 1 | -97.92% | 661 | -99.99% | - | 0.85% | 1 | -94.74% | - | -100.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| BSO Bio Santé C | 70.00K | 2.26% | - |
| Vanguard Total Stock Mkt Idx Inv | 55.39K | 1.73% | - |
| Fidelity Growth Compy Commingled Pl O | 469.48K | 1.15% | -425.27K |
| Vanguard US Total Market Shares ETF | 886.24K | 1.01% | -1.00 |
| Fidelity Growth Company Fund | 353.64K | 0.87% | -248.67K |
| Vanguard Institutional Extnd Mkt Idx Tr | 207.34K | 0.77% | - |
| Fidelity Extended Market Index | 125.45K | 0.46% | 19.92K |
| Fidelity Growth Company K6 | 163.94K | 0.40% | -132.22K |
| Fidelity Select Biotechnology | 90.30K | 0.33% | - |
| Extended Equity Market Fund B | 69.31K | 0.26% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| May 20, 2026 | Yocca Frank | Chief Scientific Officer | Sell | $7.43K |
| May 20, 2026 | Rodriguez Javier | See Remarks | Sell | $7.11K |
| May 20, 2026 | Steinhart Richard I | Chief Financial Officer | Sell | $7.43K |
| May 20, 2026 | Mehta Vimal | CEO and President | Sell | $21.11K |
| Dec 16, 2024 | O'Neill Vincent | See Remarks | Sell | $58.13 |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 4 |
| 2026 Q1 | - | - |
| 2025 Q4 | - | - |
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
BTAI Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools